Balversa
Ended Awarded Last action
- Contract number
- 36C26124N0413
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $26,464
Award facts
- Contract value 100% obligated
- $26,464.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
About this award
Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., has been awarded a $26,464.40 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide the cancer treatment drug BALVERSA. The delivery order was issued against Janssen's multiple award GSA Schedule Pharmaceuticals and Drugs contract, also known as FSS-61-IB, which has no set-aside designation and expires in April 2024. As a manufacturer of pharmaceutical goods, Janssen will deliver BALVERSA to support healthcare services for veterans at VA locations in Horsham, Pennsylvania through the end of the contract period utilizing its GSA schedule vehicle to streamline issuance of delivery orders for critical oncology medications.
Quick answers
Who was awarded contract 36C26124N0413?
36C26124N0413 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 30, 2024.
How much is contract 36C26124N0413 worth?
The government has obligated $26,464 on 36C26124N0413.
Is contract 36C26124N0413 an order under another contract?
Yes. 36C26124N0413 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0413 competed?
The extent of competition for 36C26124N0413 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award